Related Experiment Video
Updated: Jan 22, 2026

Isolation and Purification of Fungal β-Glucan as an Immunotherapy Strategy for Glioblastoma
Published on: June 2, 2023
Glucans as New Anticancer Agents
Petr Sima1, Josef Richter2, Vaclav Vetvicka3
1Department of Immunology, Institute of Microbiology, Prague, Czech Republic.
Glucans exhibit significant biological and immunological activities. Studies show glucan supplementation positively impacts cholesterol, diabetic retinopathy, and demonstrates potent cancer suppression, leading to drug approval.
Area of Science:
- Immunology
- Biochemistry
- Oncology
Background:
- Glucans have a long history of research into their biological and immunological properties.
- Research has expanded beyond immune responses to include effects on cholesterol and diabetic retinopathy.
- Significant focus has been placed on glucans' potential for cancer suppression.
Purpose of the Study:
- To review the current scientific knowledge on the diverse biological activities of glucans.
- To highlight the established and emerging therapeutic applications of glucans.
Main Methods:
- Literature review of studies on glucans.
- Analysis of research focusing on immunological, metabolic, and oncological effects.
- Examination of clinical trial data and drug approval status.
Main Results:
- Glucans demonstrate significant effects on immune reactions.
- Positive impacts of glucan supplementation on cholesterol levels and diabetic retinopathy are documented.
- Glucans show clear and significant anti-cancer effects across numerous cancer types, leading to clinical trials and drug approval.
Conclusions:
- Glucans possess a wide range of beneficial biological activities.
- The anti-cancer properties of glucans are well-established and have led to therapeutic applications.
- Further research continues to uncover the full potential of glucans in human health.
More Related Videos
Related Concept Videos
Subviral Agents
Air-entraining Agents
Masking and Demasking Agents
There are many masking agents, such as cyanide, fluoride, triethanolamine, thiourea, and 2,3-bis(sulfanyl)propan-1-ol (formerly 2,3-dimercapto-1-propanol), with the masking agent chosen based on...
Oral Hypoglycemic Agents: Glinides
Spasmolytic Agents: Chemical Classification
A major class of centrally acting spasmolytics is the α2-agonist, such as tizanidine. These drugs bind to α2-adrenoceptors, inhibiting the release of the excitatory neurotransmitter glutamate. They also...
Chemical Agents for Microbial Control

